General Archive
-
News releases
MRC Technology enters into an exclusive license agreement with Genentech
Genentech, Inc.has entered into an exclusive licence to a series of small molecule drug candidates for the potential treatment of…
-
News releases
“Skills Swap” to exploit expertise for patient benefit
Cancer Research Technology (CRT) and MRCT will ‘swap’ medical discoveries to accelerate the translation of early scientific research into patient…
-
News releases
AstraZeneca and MRC Technology form strategic alliance in discovery research, utilising shared compound libraries
The companies will combine up to 100,000 compounds from AstraZeneca’s collection with the MRC Technology compound library of approximately 50,000…
-
Articles & blogs
Adding value to early stage IP
Mike Dalrymple, Director at MRC Technology, has written an article for The Innovation Handbook about adding value to early stage…
-
News releases
O2h provides multi-FTE -synthetic chemistry services to MRCT
MRCT translates cutting edge scientific discoveries into commercial products, two of which (Tysabri and Actemra) are already on the market.…
-
News releases
MRCT’s call for targets
A major centre created by the Medical Research Council (MRC) and MRC Technology (MRCT) in order to fast-track the discovery…
-
News releases
Collaboration between Georg-August-University Göttingen, Universitätsmedizin, the University of Regensburg and MRCT
The collaboration will focus on development of a novel therapy of inflammatory and immune diseases based on the depletion of…
-
News releases
DiscoveRX, GSK & MRCT collaborate to de-orphanise GPCRs
DiscoveRX, GSK & MRCT collaboration to de-orphanise GPCRs mentioned in an article about universities driving new technology businesses in the…
-
News releases
Bicycle Therapeutics is new MRC spinout
The spin out is a new biotechnology company developing a novel technology platform for the creation of a new generation…
-
News releases
DiscoveRX GSK and MRCT collaborate to deorphanise GPCRs
The three way alliance aims to seek out natural substances that bind to G-protein-coupled receptors (GPCRs). Through the identification of…
-
News releases
Centre for Therapeutics Discovery
A major centre to fast-track the discovery and development of novel drugs will be created by the Medical Research Council…
-
News releases
Heptares secures funding
Heptares has raised GBP21 million (US$30 million) of equity finance in a successful Series A private round from three blue-chip…